Breast conservative therapy results of triple negative breast cancer.

被引：0
|
作者：
Tulusan, A. H. [1 ]
Popovich, M. [1 ]
Buehner, M. [1 ]
Keilholz, L. [1 ]
Volkholz, H. [1 ]
Lex, B. [1 ]
机构：
[1] Klinikum Bayreuth GmbH, Bayreuth, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S189 / S190
页数：2
相关论文
共 50 条
  • [41] Investigating mitotic kinesins as therapeutic targets for triple negative breast cancer.
    Cindy, F.
    Marquis, C.
    Wood, L.
    Anker, C. J.
    Howe, A. K.
    Clayton, J. E.
    Stumpff, J.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [42] Preclinical evaluation of ERX-41 in triple negative breast cancer.
    Viswanadhapalli, Suryavathi
    Liu, Xihui
    Ma, Shi-Hong
    Lee, Tae-Kyung
    Li, Mengxing
    Tang, Weiwei
    Liu, Junhao
    Li, Xiaonan
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar Rao
    Ahn, Jung-Mo
    Vadlamudi, Ratna K.
    Raj, Ganesh V.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [43] Inhibiting fatty acid synthase in operable triple negative breast cancer.
    Sardesai, Sagar D.
    Thomas, Alexandra
    Gallagher, Christopher
    Lynce, Filipa
    Ottaviano, Yvonne Lynn
    Ballinger, Tarah Jean
    Schneider, Bryan P.
    Storniolo, Anna Maria
    Bauchle, Amber
    Althouse, Sandra K.
    Perkins, Susan
    Zhang, Jian-Ting
    Miller, Kathy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Efficacy study of metronomic chemotherapy in triple negative metastatic breast cancer.
    Srinivasa, B. J.
    Kalegowda, Viveka Belathur
    Badarkhe, Girish
    Sridhar, P. S.
    Khanderia, Mansi
    Tousif, T.
    Lalkota, Bhanu
    Kodad, Shruthy
    Musheb, Mohamed
    Sapkota, Sulav
    Nayak, Radheshyam
    Ajaikumar, Basavalinga S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Prognostic significance of NLR kinetics in operable triple negative breast cancer.
    Ganta, Ranga Raman
    Nasaka, Srividya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Characterizing the gut microbiome of patients with triple-negative breast cancer.
    Swoboda, April T.
    Sharma, Anukriti
    Olopade, Olufunmilayo I.
    Nanda, Rita
    Gilbert, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [48] Patterns of mutation enrichment in metastatic triple-negative breast cancer.
    Saravia, Cesar H.
    Flores, Claudio J.
    Schwarz, Luis Jesus
    Bravo, Leny
    Zavaleta, Jenny
    Araujo, Jhajaira M.
    Neciosup, Silvia P.
    Pinto, Joseph A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Lymphatic and vascular invasion patterns in triple-negative breast cancer.
    Yaman, S.
    Gumuskaya, B.
    Ozkan, C.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345